Literature DB >> 34228600

Bilateral post fever retinitis with retinal vascular occlusions following severe acute respiratory syndrome corona virus (SARS-CoV2) infection.

Padmamalini Mahendradas1, Prathibha Hande2, Aditya Patil1, Ankush Kawali1, Srinivasan Sanjay1, Syed Asrar Ahmed3, Sherina Thomas2, Rohit Shetty4.   

Abstract

Introduction: As the world fights the pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), several reports of retinal manifestations of the disease are emerging. Post fever retinitis is a well reported ocular inflammatory reaction to multiple invasive agents, be it virus, bacteria or other microbial agent.Purpose: We report an interesting case of bilateral multifocal retinitis with multiple vascular occlusions in a patient, three weeks after a febrile illness.
Results: Investigations to ascertain the cause of fever resulted in identifying ephemeral seropositivity for several different Ribonucleic acid (RNA) viruses. The retinitis was managed with systemic steroids, doxycycline and anticoagulants with improvement in vision.
Conclusion: High and persistent seropositive response against (SARS-CoV-2) helped us to narrow it as the causative agent but the cross reactivity of SARS-CoV-2 with other viruses can be misleading and needs careful interpretation.

Entities:  

Keywords:  COVID-19; Ig M; IgG SARS-CoV-2; Multifocal retinitis; RT- PCR; SARS-CoV-2; vascular occlusions

Year:  2021        PMID: 34228600     DOI: 10.1080/09273948.2021.1936564

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Commentary: Sight-threatening intraocular infection in patients with COVID-19 in India.

Authors:  Padmamalini Mahendradas; Srinivasan Sanjay; Sai Bhakti Mishra; Ankush Kawali; Bhujang K Shetty
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

2.  An analysis of the clinical profile of patients with uveitis following COVID-19 infection.

Authors:  Sudha K Ganesh; Amanda Mohanan-Earatt
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.